KANGASMETSA, JUSSI J.,CARLING, WILLIAM R.,MARTOS, JOSE L.,WANG, JENNY W.,WOODWARD, DAVID F.
申请号：
CA2860392
公开号：
CA2860392C
申请日:
2012.12.19
申请国别(地区):
CA
年份:
2016
代理人:
摘要：
The present invention provides a compound that is represented by the following general formula (I) wherein R1, R2, R4, R5, R6, R7, X, W, X and Y are as defined in the specification. The compounds may be administered to treat DP1, FP, EP1, TP and/or EP4 receptor mediated diseases or conditions.
